| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $18.5B | $18.8B | $18.9B | $26.7B |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | $2.0B | $2.1B | $2.4B | $2.3B |
| Operating Income | — | — | — | — |
| Net Income | $-0.4B | $2.2B | $1.1B | $8.1B |
| EPS (Basic) | $-0.68 | $3.73 | $1.72 | $12.61 |
| EPS (Diluted) | $-0.68 | $3.72 | $1.71 | $12.59 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $413.5B | $389.4B | $379.3B | $364.2B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.8B | $0.6B | $0.6B |
| Total Liabilities | $399.6B | $377.1B | $366.6B | $355.1B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | $13.2B | $11.5B | $11.8B | $8.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $2.0B | $2.2B | $3.4B | $2.7B |
| Investing Cash Flow | $-13.3B | $-11.5B | $-5.5B | $-7.3B |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $10.9B | $9.6B | $2.1B | $4.6B |